This is an active lawsuit

Zantac Lawsuit

Cancer Settlements and Compensation

Secure Your Spot

Zantac is a heartburn drug that has recently been pulled from the market in 2022 due to mounting lawsuits claiming the drug causes cancer. 1 Zantac, chemically known as ranitidine, first raised concern in 2018. 1

In 2020, Zantac was pulled from the market due to is linked to unacceptable levels of N-nitrosodimethylamine (NDMA), a probable carcinogen. 2 & 4

Zantac and genetic ranitidine were used by millions of Americans prior to the recall. 4

More than 2,000 lawsuits have been filed in federal courts in Florida alone and the first federal court trials are scheduled for some time next year, in 2023. 1 & 2

If you or a loved one have suffered injuries such as cancer, and even death, please take the time to read this article and determine if you are a candidate for the ongoing Zantac lawsuits.

Zantac Injuries and Side Effects

Lawsuits claim that there is an impurity called N-nitrosodimethylamine (NDMA), a probable carcinogen, that has directly resulted in the plaintiffs' cancer diagnosis.1 

GSK and Sanofi, former drug manufacturers of ranitidine, claim there is no scientific evidence to indicate that Zantac, or its generic version of ranitidine, causes cancer. 2 

Zantac makers however claim that the NDMA levels found in the medicine are close to the common found in grilled, smoked, packaged, and frozen meats and fish. 1 & 2

Yet studies have shown that Zantac and the generic medicine Remitine breaks down into NDMA, a known carcinogenic. 5

Recent studies have even found that certain diets and the storage conditions of ranitidine in high temperatures can cause the pill to become even more dangerous with extremely dangerous levels of NDMA. 5

Zantac Case Information & Settlements

Although the first Zantac case has to be voluntarily dismissed from courts, generic drugmakers agreed to pay a combined settlement of $500,000 to Bayer, the plaintiff alleging the medication caused his esophageal cancer. 2 & 4

The plaintiffs' attorneys maintain "Ultimately, the overwhelming body of science supports the fact that (Zantac) degrades into NDMA, a chemical recognized by the FDA as a Class 1 genotoxic carcinogen, and causes cancer." 2

Studies have shown that Zantac and the generic medicine Remitine breaks down into NDMA, a known carcinogenic

Past Zantac Lawsuits

The first Zantac lawsuit over cancer that was to go before a jury was dismissed after a settlement agreement was reached with the plaintiff and generic drug makers. 4

  • 2022 Voluntary dismissal of the lawsuit after settlement 2 & 4

Secure your settlement - Speak with a Zantac lawyer

Have you or a loved one been diagnosed with Bladder cancer after using Zantac?

Take the time to see if you qualify.

Lawyers

Current Zantac Lawsuits

As of August 2022, trials are expected to begin in California and federal court in early 2023. 4

  • 2022 Four Zantac cancer lawsuits are scheduled in the state of California 4

Generic drugmakers agreed to pay a combined settlement of $500,000 for the first Zantac case to be settled out of court

Eligibility for Zantac lawsuit

Millions of America have taken Zantac and the generic version ranitidine for heartburn and acid reflux treatment.

Zantac injury lawsuits claim manufacturers of the drug knew of the NDMA contamination in their products and that these products resulted in their various cancer diagnoses. 4 & 5

Currently, all litigation is in the initial stages and trials should be going to court within the upcoming year. 9

If you are a loved one who was diagnosed with mesothelioma or ovarian cancer due to the usage of J&J talc powder, please have your case reviewed by a legal professional.

FDA & Scientific Studies on Zantac

The FDA found that safe daily NDMA exposure is 96 nanograms (ng), yet independent pharmacies have found more than 3 million ng in each Zantac pill. 4

  • 2019 Valisure, an online pharmacy, found that each Zantac pill exposed users to unsafe levels of NDMA, a know human carcinogen 4
  • 2020 U.S. regulators determined unacceptable levels of NDMA can occur in some ranitidine products when over time and when stored at high temperatures 1

Studies have shown that Zantac and the generic medicine Remitine breaks down into NDMA, a known carcinogenic

Questions asked by Zantac Lawyers

Have you developed cancer within 20 years of the last time taking Zantac?

Medical records and proof of a Zantac prescription will need to be provided for the lawsuit.

Have you been diagnosed with cancer at age 89 or younger?

Many potential clients have been diagnosed with cancer at the age of 89 or younger.

Have you taken Zantac at least once a week for one year before being diagnosed with cancer?

Evidence to confirm the timeframe of Zantac usage and later cancer diagnosis is needed. Past lawsuits have seen individuals seeking compensation after a cancer diagnosis following the use of Zantac for at least one year. 9

Do you have evidence such as a Zantac prescription? (i.e. medical records or receipts for over-the-counter purchases)

Proof of a Zantac prescription will need to be provided for the lawsuit.

Zantac Lawsuit FAQs

How Does Zantac Contribute to Cancer?

Who is Eligible to File a Lawsuit?

What is the Status of Zantac Lawsuits?

Has There Been a Zantac Settlement?

How do I get my case reviewed by a Zantac lawyer?

Start with a complimentary case evaluation

Case reviews are provided for complimentary unless you are awarded compensation for your Zantac Lawsuit.

Please answer the following preliminary questions so we can better connect you with a qualified law firm.

6 Cited Articles

  • https://www.reuters.com/legal/gsk-says-plaintiffs-seeks-voluntary-dismissal-first-zantac-lawsuit-2022-08-16/
  • https://www.fiercepharma.com/pharma/opening-round-zantac-litigation-gsk-scores-decisive-win
  • https://www.bloomberg.com/news/articles/2022-08-16/first-zantac-cancer-case-set-for-trial-in-us-settles-instead

Share this page

Zantac

Implicated Products

Zantac manufactured by Sanofi, GSK, Bayer AG, Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd, and Dr. Reddy’s Laboratotes, Inc.

Carcinogen

N-nitrosodimethylamine (NDMA)

Related Injuries

Bladder cancer; Esophageal cancer; Gastric cancer; Liver cancer; Pancreatic cancer

Top Settlement/Jury Verdict

$500,000 (settlement out of court)

Defendants

Pfizer and GlaxoSmithKline; Sanofi US Services Inc.; Sanofi-Aventis U.S. LLC; Chattem; Inc.; Boehringer Ingelheim

THINK YOU MAY QUALIFY?
We use essential cookies to make our site work. We use non-essential cookies to improve user experience and analyze website traffic. By using this site, you agree to our website's cookie use as described in ourCookie Policy.